Back to Transactions
Healthcare
2023

Seventure and minority shareholders have sold TargEDys to Biocodex

TargEDys

TargEDys is an innovative French biotechnology that is pioneering disruptive microbiome-based solutions, mainly addressing weight management, growth and anxiety health challenges. The company develops and provides unique next-generation precision probiotic solutions, presenting detailed mechanism of actions and proven in-vivo efficacy.

The Deal

With the support of Biocodex, TargEDys will continue its ambitious growth strategy of developing a multi-technology scalable platform and investing in science.

Our Perspective

This transaction further adds to Lincoln International’s track-record in microbiome and consumer healthcare space.

Related
Perspectives

Connect with a Senior Team Member

Meet our Senior Team

François Rispoli
I strive to be a trusted advisor to my clients, adding value throughout their journey, and helping them to reach successful outcomes.

François Rispoli

Managing Director

Paris

Nguyen Mathieu 616x616
I strive to build solid and trustworthy relationships with my clients through transparent communication and a tailor-made, value-added approach, helping them to reach the best outcome.

Mathieu Nguyen

Vice President

Paris

View More Transactions in Healthcare

nspm has been sold to Cactus Life Sciences, a subsidiary of Cactus Global

Healthcare

Lincoln International advised ECONA on receiving strategic advice on potential options for nexmed

Healthcare

Lincoln International advised Gilde Healthcare on its agreement to sell RAD-x to Swiss Life Asset Managers and Vesper Infrastructure Partners

Healthcare

Lincoln International advised Bridgepoint Growth on the acquisition of Identicare from Animalcare Group

Healthcare

Lincoln International advised Varsity Healthcare Partners on the sale of Angels of Care Pediatric Home Health to Nautic Partners

Healthcare

Lincoln International advised Aquiline Capital Partners on the acquisition of Health Prime from GPB Capital Holdings

Healthcare

Lincoln International advised Talisman Capital Partners on the sale of ADVOCATE RCM to Ventra Health, a portfolio company of Varsity Healthcare Partners

Healthcare

Lincoln International advised Mars on the sale of Diamond Animal Health to Veterinary Pharmaceutical Solutions, a portfolio company of Granite Creek Capital Partners

Healthcare
View All

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.